Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,371,413 Pentamethylenediisocyanate, method for producing pentamethylenediisocyanate, polyisocyanate composition,...
A Pentamethylene diisocyanate is obtained by phosgenating pentamethylenediamine or its salt obtained by a biochemical method, and contains 5 to 400 ppm of a...
US-9,371,412 Process for imparting grease, oil and water repellence to substrates
A process for imparting grease, oil and water repellence to a substrate comprises applying by means of a printing process on at least a portion of the surface...
US-9,371,411 Abrasion-resistant and alkali-resistant coatings or moulded bodies having a low-energy surface
The invention relates to a composition for producing abrasion-resistant and alkali-resistant layers or molded bodies having a low-energy surface, said...
US-9,371,410 Polyurethane elastomers for use in subsea pipeline insulation
Polyurethane systems that cure similarly to systems based on mercury catalysts contain 1,4-butanediol and a zinc carboxylate catalyst. These systems cure and...
US-9,371,409 Curing compositions having low-free amounts of methylenedianiline
A process for preparing a curing composition of a coordination complex comprising methylenedianiline (MDA) and a salt, and less than 1000 of free MDA. The...
US-9,371,408 Polymer and method for using the same
The invention relates to a polymer derived from: reaction of glycidyl (meth)acrylate, allyl glycidyl ether or [(vinyloxy)methyl]oxirane with ammonia or primary...
US-9,371,407 Catalyst system with three metallocenes for producing broad molecular weight distribution polymers
Disclosed herein are polymerization processes for the production of olefin polymers. These polymerization processes use a catalyst system containing three...
US-9,371,406 Apparatus and process for making high-pressure polyethylene polymers and copolymers
Embodiments of the invention provide an apparatus for the manufacture of polyethylene and polyethylene copolymers. The apparatus includes a primary compressor...
US-9,371,405 Nucleation in aqueous polymerization of fluoromonomer
A process is provided for polymerizing fluoromonomer in an aqueous medium, wherein a dispersion of essentially surfactant-free hydrocarbon-containing oleophilic...
US-9,371,404 System and method for rapid transitioning of polyolefin processes from one product to another
A gas-phase polyolefin reactor system for rapidly transitioning from one polyolefin product to another is disclosed. The reactor system comprises a control...
US-9,371,403 Hydrogenation of diene-based polymers
This invention relates to a process for the hydrogenation of diene-based copolymers in the presence of catalysts on specific carrier materials containing at...
US-9,371,402 Method for producing cross-linked hyaluronic acid
A method for producing a cross-linked hyaluronic acid in accordance with the present invention comprises: (a) cross-linking at least one polymer at a...
US-9,371,401 Low energy method for the preparation of non-derivatized nanocellulose
A low energy method for the preparation of nanocellulose using selected organic or inorganic swelling agents. The use of these swelling agents allows opening up...
US-9,371,400 Thermal regulating building materials and other construction components containing phase change materials
A material for energy management and peak energy reduction in a building structure, comprises an insulative base material, a first phase change material, and a...
US-9,371,399 Methods for producing alkali cellulose and cellulose ether
A degree of polymerization of cellulose ether is accurately controlled, and quality and a manufacturing process of the cellulose ether are stabilized. There is...
US-9,371,398 Methods for preparing alkali cellulose and cellulose ether
Provided is a method for efficiently preparing alkali cellulose having a uniform alkali distribution. More specifically, provided are a methods for preparing...
US-9,371,397 CTLA4-Ig immunoadhesins
The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.
US-9,371,396 Anti-CD22 anti-idiotypic antibodies and uses thereof
The present invention describes the generation of an anti-idiotype single-chain Fv (scFv) antibody specific for the murine (RFB4), chimeric (SM03) and humanized...
US-9,371,395 Anti B7-H3 antibody
An antibody exhibiting antitumor activity that binds to B7-H3, a functional fragment of the antibody, a pharmaceutical composition that includes the antibody or...
US-9,371,394 Monoclonal antibodies and detection methods for phosphinothricin-N-acetyl-transferase enzyme
Described herein are monoclonal antibodies and methods useful for determining and quantitating the presence of a phosphinothricin-N-acetyl-transferase enzyme....
US-9,371,393 Class I anti-CEA antibodies and uses thereof
The present invention provides compositions and methods of use of humanized, chimeric or human Class I anti-CEA antibodies or fragments thereof, preferably...
US-9,371,392 Treatment of complex regional pain syndrome using denosumab
Disclosed herein are methods of treating pain using comprising RANK/RANKL antagonists.
US-9,371,391 Anti-human IL-23 receptor antibody and encoding polynucleotides
[Problem] An object of the present invention is to provide an anti-human IL-23R antibody having excellent activity and/or cross-reactivity compared to...
US-9,371,390 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
The disclosure relates to methods and compositions effective in the diagnosis, prognosis and treatment of human hematopoietic cancers. In particular, the...
US-9,371,389 Anti-human XCR1 antibodies
An object of the present invention is to provide a monoclonal antibody binding to human XCR1, wherein the antibody binds to linear or discontinuous epitopes...
US-9,371,388 High affinity antibody antagonists of interleukin-13 receptor alpha 1
High affinity antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are effective in the inhibition of...
US-9,371,387 Composition for prevention or treatment of ischemic cardiac disease, comprising inhibitor against age-albumin...
Disclosed is a pharmaceutical composition for the prevention or treatment of ischemic heart diseases, comprising as an active ingredient an inhibitor which acts...
US-9,371,386 Methods and compositions for bi-specific targeting of CD19/CD22
Methods and composition involving genetically engineered targeting conjugates with reversed orientation of VL and VH chains are provided. For example, in...
US-9,371,385 Compositions and methods for diagnosing and treating an inflammation
A method of treating a graft rejection disease in a subject in need thereof, the method comprising administering to said subject a therapeutically effective...
US-9,371,383 Anti-ASIC1 antibodies and uses thereof
The present invention provides antibodies and antigen-binding fragments thereof that specifically bind to cells expressing acid-sensing ion channel-1 (ASIC1)....
US-9,371,382 Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP
A specific and sensitive in vitro ELISA assay and diagnostic test kit is disclosed for determining levels of NT-proBNP protein in a variety of bodily fluids,...
US-9,371,381 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
The present invention relates to polypeptides derived from single domain heavy chain antibodies directed to Tumor Necrosis Factor-alpha. It further relates to...
US-9,371,380 Antitumor agent and therapeutic effect prediction method for patients with KRAS-mutated colorectal cancer
This invention provides a method for predicting a therapeutic effect of chemotherapy that uses an antitumor agent comprising ...
US-9,371,379 Methods for treating malaria by administering an antibody that specifically binds angiopoietin-2 (ang-2)
The present invention provides methods for treating malaria by administering to a patient in need thereof a pharmaceutical composition comprising an antibody...
US-9,371,378 Anti-C5a antibodies
The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for...
US-9,371,377 Anti-C5 antibodies having improved pharmacokinetics
The disclosure provides antibodies that are useful for, among other things, inhibiting terminal complement (e.g., the assembly and/or activity of the C5b-9 TCC)...
US-9,371,376 Anti-PHF-tau antibodies and their uses
Anti-PHF-tau antibodies and methods of making and using them are disclosed.
US-9,371,375 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
The present invention provides for recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens, along with...
US-9,371,374 HCV core lipid binding domain monoclonal antibodies
The present invention relates to monoclonal antibodies for the detection of HCV antigen. More specifically, the invention describes antibodies against HCV core...
US-9,371,373 Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method,...
Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunization method, and treatment method for rotavirus infections, wherein said...
US-9,371,372 Human cytomegalovirus neutralizing antibodies and use thereof
The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody...
US-9,371,371 Engineering of immunoglobulin domains
The present invention provides a single domain antibody (sdAb) scaffold comprising one or more than one non-canonical disulfide bond in the framework region...
US-9,371,370 Coagulation factor VII polypeptides
The present invention relates to modified coagulation Factor VII polypeptides exhibiting increased resistance to antithrombin inactivation and enhanced...
US-9,371,369 Extended recombinant polypeptides and compositions comprising same
The present invention relates to compositions comprising biologically active proteins linked to extended recombinant polypeptide (XTEN), isolated nucleic acids...
US-9,371,368 Compositions and methods for immunomodulation in an organism
The present invention relates to a therapeutic polypeptide and methods for its creation and use for modulating an immune response in a host organism in need...
US-9,371,367 Selective delivery molecules and methods of use
Disclosed herein is a selective delivery molecule comprising: (a) an acidic sequence (portion A) which is effective to inhibit or prevent the uptake into cells...
US-9,371,366 Influenza virus vaccines and uses thereof
Provided herein are chimeric influenza hemagglutinin (HA) polypeptides, compositions comprising the same, vaccines comprising the same, and methods of their use.
US-9,371,365 Modified compstatin with peptide backbone and C-terminal modifications
Compounds comprising peptides capable of binding C3 protein and inhibiting complement activation are disclosed. These compounds display greatly improved...
US-9,371,364 Dual-targeted therapeutic peptide for nasopharyngeal carcinoma, nanoparticles carrying same and uses thereof
Disclosed is a dual-targeted therapeutic peptide for nasopharyngeal carcinoma formed by covalently linking a targeted therapeutic peptide for nasopharyngeal...
US-9,371,363 Peptides and their use
The invention relates to peptides, and peptide variants thereof, in which substantially all of the amino acids in the amino sequence of said peptide are the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.